ALB Albemarle Corporation
Low-cost lithium franchise priced near mid-cycle; value hinges on whether prices normalize, not on volume growth.
The story
Albemarle is a top-three global lithium producer with low-cost Atacama brine and Greenbushes spodumene stakes, plus steady bromine and catalysts businesses. It is a cyclical commodity producer coming out of a severe 2023-2025 lithium price collapse; TTM revenue has turned up and margins are positive again. Long-run EV and grid-storage demand supports volume growth, but pricing power is limited and returns depend on where prices sit in the cycle.
Growth in year 1 reflects early lithium price recovery and volume ramps. The 18% target margin is a mid-cycle level, well below the 2022 peak of 35% and above the trough, and it is supported by tier-one resource costs. Sales-to-capital rises from 0.56 to 0.8 as the heavy capex wave rolls off. Beta of 1.4 and a small failure probability reflect commodity leverage and $1.6B of net debt.
Value drivers
| Revenue growth (Y1) | 12.0% |
| Terminal growth | 3.5% |
| Forecast horizon | 10y |
| Target operating margin | 18.0% |
| Years to target margin | 5 |
| Sales-to-capital | 0.80 |
| Beta | 1.40 |
| Failure probability | 4.0% |
| Cost of capital (WACC) | 10.6% |
| Terminal WACC | 9.2% |
Valuation bridge
| PV of explicit FCFF | 1.63B |
| PV of terminal value | 7.23B |
| Equity value | 4.61B |
| ÷ shares → per share | $39.10 |
Projected free cash flow to the firm
| Yr | Revenue | Growth | Margin | NOPAT | Reinvest | FCFF | PV |
|---|---|---|---|---|---|---|---|
| 1 | 6.62B | 12.0% | 8.3% | 432.03M | 886.19M | -454.16M | -410.51M |
| 2 | 7.35B | 11.1% | 10.7% | 621.08M | 914.41M | -293.34M | -239.66M |
| 3 | 8.09B | 10.1% | 13.1% | 839.45M | 928.75M | -89.31M | -65.95M |
| 4 | 8.83B | 9.2% | 15.6% | 1.09B | 927.14M | 159.09M | 106.20M |
| 5 | 9.56B | 8.2% | 18.0% | 1.36B | 907.85M | 451.50M | 272.43M |
| 6 | 10.26B | 7.3% | 18.0% | 1.46B | 869.64M | 588.64M | 321.04M |
| 7 | 10.90B | 6.3% | 18.0% | 1.55B | 811.86M | 738.77M | 364.20M |
| 8 | 11.49B | 5.4% | 18.0% | 1.63B | 734.54M | 899.65M | 400.89M |
| 9 | 12.00B | 4.4% | 18.0% | 1.71B | 638.46M | 1.07B | 430.32M |
| 10 | 12.42B | 3.5% | 18.0% | 1.77B | 525.13M | 1.24B | 451.97M |
Key risks
- Chinese and African lepidolite/spodumene oversupply keeps lithium prices depressed
- Sodium-ion or chemistry shifts erode lithium intensity per kWh
- Chilean resource nationalism (Codelco partnership terms) compresses Atacama economics
Catalysts
- Sustained lithium carbonate price recovery as high-cost supply curtailments stick
- Capex cuts converting to positive free cash flow and deleveraging